10x Genomics, Inc.
NASDAQ:TXG
22.08 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 359.284 | 219.746 | 587.447 | 663.603 | 424.166 | 65.08 | 47.857 |
| Short Term Investments
| 29.411 | 210.238 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 388.695 | 429.984 | 587.447 | 663.603 | 424.166 | 65.08 | 47.857 |
| Net Receivables
| 114.832 | 104.211 | 85.254 | 51.208 | 33.371 | 29.566 | 13.341 |
| Inventory
| 73.706 | 81.629 | 59.966 | 29.959 | 15.27 | 8.57 | 4.838 |
| Other Current Assets
| 18.789 | 16.578 | 14.924 | 29.596 | 8.033 | 3.02 | 2.071 |
| Total Current Assets
| 596.022 | 635.035 | 747.591 | 774.366 | 480.84 | 106.236 | 68.107 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 344.932 | 359.21 | 230.41 | 119.823 | 48.821 | 11.127 | 6.925 |
| Goodwill
| 4.511 | 4.511 | 4.511 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 16.616 | 22.858 | 25.397 | 22.354 | 22.366 | 0 | 0 |
| Goodwill and Intangible Assets
| 21.127 | 27.369 | 29.908 | 22.354 | 22.366 | 0 | 0 |
| Long Term Investments
| 0 | 4.974 | 7.598 | 8.474 | 52.327 | 5.008 | 0 |
| Tax Assets
| 0 | -4.974 | -7.598 | -8.474 | -74.693 | 0 | 0 |
| Other Non-Current Assets
| 3.062 | 7.366 | 10.917 | 12.798 | 76.262 | 1.939 | 0.577 |
| Total Non-Current Assets
| 369.121 | 393.945 | 271.235 | 154.975 | 125.083 | 18.074 | 7.502 |
| Total Assets
| 965.143 | 1,028.98 | 1,018.826 | 929.341 | 605.923 | 124.31 | 75.609 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 15.738 | 21.599 | 17.351 | 4.709 | 13.028 | 8.792 | 5.443 |
| Short Term Debt
| 11.521 | 9.037 | 5.131 | 5.936 | 9.882 | 4.187 | 4.224 |
| Tax Payables
| 5.049 | 4.079 | 4.622 | 8.649 | 1.087 | 0.738 | 0.163 |
| Deferred Revenue
| 13.15 | 7.867 | 5.34 | 4.472 | 3.297 | 2.776 | 1.827 |
| Other Current Liabilities
| 86.753 | 92.454 | 82.535 | 103.009 | 36.842 | 16.607 | 10.647 |
| Total Current Liabilities
| 127.162 | 130.957 | 110.357 | 118.126 | 63.049 | 32.362 | 22.141 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 83.849 | 86.139 | 76.847 | 57.042 | 19.837 | 25.489 | 6.335 |
| Deferred Revenue Non-Current
| 8.814 | 3.165 | 0 | 0 | 0.834 | 1.102 | 0.713 |
| Deferred Tax Liabilities Non-Current
| -0 | -3.165 | 0 | 0 | 101.029 | 284.573 | 158.415 |
| Other Non-Current Liabilities
| 4.275 | 6.141 | 14.054 | 15.101 | 1.091 | 0.771 | 0.514 |
| Total Non-Current Liabilities
| 96.938 | 92.28 | 90.901 | 72.143 | 122.791 | 311.935 | 165.977 |
| Total Liabilities
| 224.1 | 223.237 | 201.258 | 190.269 | 185.84 | 344.297 | 188.118 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 605.923 | 243.244 | 158.414 |
| Common Stock
| 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -1,284.42 | -1,029.321 | -863.321 | -805.098 | -262.367 | -231.116 | -118.631 |
| Accumulated Other Comprehensive Income/Loss
| -0.429 | -4.335 | 0.022 | -0.05 | -0.046 | -0.037 | -0.015 |
| Other Total Stockholders Equity
| 2,025.89 | 1,839.397 | 1,680.865 | 1,544.218 | 76.571 | -232.079 | -152.278 |
| Total Shareholders Equity
| 741.043 | 805.743 | 817.568 | 739.072 | 420.083 | -219.987 | -112.509 |
| Total Equity
| 741.043 | 805.743 | 817.568 | 739.072 | 420.083 | -219.987 | -112.509 |
| Total Liabilities & Shareholders Equity
| 965.143 | 1,028.98 | 1,018.826 | 929.341 | 605.923 | 124.31 | 75.609 |